As much as so many were excited yesterday about the enrollment of the first patient in a CIRM-funded clinical trial, I did not see a mention of a very important element. The patient. Our excitement about the clinical trial moving forward is understandable, but we also need to keep a sober perspective on the fact […]
The news of CIRM and clinical trial: don’t forget the patient Read More »
I have posted before about publishing trends in the iPS cell field here and in here…. but where do things stand today? Here, I provide an important update. What’s going on now? Here I provide answers to the key questions. How many papers are there on iPS cells? An interesting and unexpected trend for this
Everything you need to know about publishing in the iPS cell field Read More »
This year’s World Stem Cell Summit is looking to be an amazing meeting and I highly recommend that you attend. By going you can learn a great deal about stem cells whether you are a stem cell scientists or not. But in addition, the Summit offers the opportunity to learn a lot more including about
Many reasons why you should attend this year’s World Stem Cell Summit! Read More »
There has been a largely media-fed hullabaloo about the salary for the new Chair of CIRM, the California Institute for Regenerative Medicine, $400,000. Now don’t get me wrong, that sounds like a lot of money to me personally, but we need to put it in perspective and when we do, the salary is reasonable and
California pays its sports coaches alone more than the entire payroll of CIRM Read More »
The CIRM Board is meeting today and will decide on its future Chair via an election. There are two candidates, Jonathan Thomas (nominated by Bill Lockyer, the California state treasurer) and Frank Litvack, nominated by state controller, John Chang. Thomas is described as a Bond financier, while Litvack is an L.A. cardiologist and businessman with
And the new leader of CIRM is… Read More »
Paul, how can I make money from stem cells? Someone recently asked me this question and more often I get asked “Which stem cell companies do YOU like as a stem cell scientist?” Just today an article went out that said that the global market for stem cell products will be $65 billion by 2015.
How to make money from stem cells Read More »
Tonight the Republican candidates for President of the United States will face off in their first fully-attended debate. The frontrunner by far to win the Republican nomination and face President Obama in the Fall of 2012 is Mitt Romney. Although that is not saying a whole lot given the weakness of the Republican group of
President Romney and stem cells: the road to disaster Read More »
Ideas are the foundation of stem cell research, but funding makes those ideas a reality. We talk a lot about governmental funding of stem cell research through CIRM and NIH. The funding from these agencies is essential and will undoubtedly lead to new treatments and cures, possibly for millions of patients. But there is another
Why invest in stem cells? Progress, Patients, and Patents Read More »
A report will be issued today of the economic impact of CIRM on California. The Sac Bee and FierceBiotech are reporting on the economic infusion that CIRM has provided to the state. On average during its existence, CIRM has created 8 jobs day for the state of California. The jobs mostly consist not surprisingly of
Report: CIRM creates 8 jobs a day for California Read More »
It has been a rollercoaster few months between the anti-hESC court cases as well as Geron and Advanced Cell Technology (ACT) receiving the OK from the FDA to proceed with initial clinical trials of stem cell treatments. It’s OK to be excited about the clinical trials and I for one am, but we have to
Challenges translating stem cell treatments to patients Read More »